4.8 Article

A Functional Role for Antibodies in Tuberculosis

期刊

CELL
卷 167, 期 2, 页码 433-+

出版社

CELL PRESS
DOI: 10.1016/j.cell.2016.08.072

关键词

-

资金

  1. NIH [R01 AI080289, AI102660]
  2. DARPA [BAA-11-65]
  3. Harvard University Center for AIDS Research (CFAR) [P30 AI060354]
  4. NHMRC [APP1036470]
  5. Bill and Melinda Gates Foundation CAVD (Leveraging Antibody Effector Function) [OPP1032817]
  6. Pozen Family Foundation
  7. Doris Duke Medical Research Foundation
  8. Burroughs Wellcome Foundation
  9. Ragon Institute of MGH, MIT, and Harvard
  10. [T32 AI007387]

向作者/读者索取更多资源

While a third of the world carries the burden of tuberculosis, disease control has been hindered by a lack of tools, including a rapid, point-of-care diagnostic and a protective vaccine. In many infectious diseases, antibodies (Abs) are powerful biomarkers and important immune mediators. However, in Mycobacterium tuberculosis (Mtb) infection, a discriminatory or protective role for humoral immunity remains unclear. Using an unbiased antibody profiling approach, we show that individuals with latent tuberculosis infection (Ltb) and active tuberculosis disease (Atb) have distinct Mtb-specific humoral responses, such that Ltb infection is associated with unique Ab Fc functional profiles, selective binding to Fc gamma RIII, and distinct Ab glycosylation patterns. Moreover, compared to Abs from Atb, Abs from Ltb drove enhanced phagolysosomal maturation, inflammasome activation, and, most importantly, macrophage killing of intracellular Mtb. Combined, these data point to a potential role for Fc-mediated Ab effector functions, tuned via differential glycosylation, in Mtb control.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据